Call for Papers  

Article Details

Mini-Review Article

Role of Cerium Oxide Nanoparticles and Doxorubicin in Improving Cancer Management: A Mini Review

[ Vol. 29 , Issue. 33 ]


Agnishwar Girigoswami, Harini Adhikesavan, Shurfa Mudenkattil, Sobita Devi and Koyeli Girigoswami*   Pages 2640 - 2654 ( 15 )


Cancer is one of the significant issues with public health and the second leading cause of death worldwide. The three most lethal cancers in the general population are stomach, lung, and liver cancers, in which lung and breast cancers cause the majority of cancer-associated deaths among men and women, respectively. CeO2 nanoparticles have a cytoprotectant effect in normal cells and a cytotoxic effect in cancer cells that enables them to induce the reactive oxygen species (ROS) production within cancer cells, which in turn develops reactive nitrogen species (RNS) that interfere with intracellular activities, and this property makes them an excellent anticancer agent. Because of its biofilm suppression, free radical scavenging ability, redox activity, and other unique properties, attention has been bestowed on cerium oxide nanoparticles as a potential alternative to solve many biomedical issues in the future. This review mainly focuses on the combinatorial effect of cerium dioxide nanoparticles and Doxorubicin in cancer management.


Cancer, cerium oxide, doxorubicin, nanoparticles, bionanotechnology, doxorubicin.


Read Full-Text article